ENZ - Enzo Biochem, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue104,713107,804102,77397,599
Cost of Revenue60,38559,47857,19054,772
Gross Profit44,32848,32645,58342,827
Operating Expenses
Research Development3,2102,9283,5243,350
Selling General and Administrative49,59245,77150,12549,857
Non Recurring----
Total Operating Expenses116,877110,952113,175110,263
Operating Income or Loss-12,164-3,148-10,402-12,664
Income from Continuing Operations
Total Other Income/Expenses Net74664456,76210,372
Earnings Before Interest and Taxes-12,164-3,148-10,402-12,664
Interest Expense---136-245
Income Before Tax-11,418-2,50446,360-2,292
Income Tax Expense-1,097821,074-7
Minority Interest----
Net Income From Continuing Ops-10,321-2,50445,286-2,285
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-10,321-2,50445,286-2,285
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-10,321-2,50445,286-2,285